Baciarello G, Delva R, Gravis G, Tazi Y, et al. Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial. Eur Urol 2021 Nov 14. pii: S0302-2838(21)02117.
PMID: 34789394